Silver Prices Consolidate in Narrow Range Throughout the Week as Market Awaits Fresh Catalysts Ashok Leyland Q4 PAT Hits Record 1405 Crore Board Declares 250 Dividend Big Techs AI Data Centers Spark Power Crisis for 49000 California Homes Tax Season 2025 New Wrinkles for Online Sellers and EV Owners May Offer Savings Rosen Law Firm Alerts Sportradar Group Investors to Class Action Deadline in Securities Fraud Lawsuit AIFueled Surge European Stocks Soar Over 100 in Blockbuster Rally XIFR Q1 2026 Earnings Massive EPS Beat Drives Positive Market Reaction Zillow Group ZG Q1 2026 Earnings EPS Surges Past Estimates But Stock Dips on Broader Market Headwinds ARW Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response Avino Silver Gold Mines Ltd ASM Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control BBY Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Stock Rises Foresight Autonomous Holdings FRSX Rallies 3 Amid Renewed Interest Key Levels to Watch Insight Digital Partners II DYOR Holds Steady Near 10 as Market Watches Key Support and Resistance Levels Revelation Biosciences Inc REVB Edges Lower Maintains Support Near 101 Urban One UONEK Surges 7 as Media Stock Consolidates Above Key Support Syndax Pharmaceuticals SNDX Holds Steady Near 20 as Market Watches Key Levels ixigo Partners with Uber and redBus to Integrate Cab and Bus Bookings in Train App agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge PowerBank Corporation SUUN Slips Marginally as Traders Eye Key Support at 098 TBH Q4 2025 Earnings Massive EPS Miss as Losses Significantly Exceed Expectations AMPH Q1 2026 Earnings EPS Misses Estimates Stock Gains Ground HRMY Q1 2026 Earnings EPS Misses Estimates Stock Slips on Profitability Concerns ICL Q1 2026 Earnings EPS Beats Estimates by 1458 Stock Slightly Down NWSA Q1 2026 Earnings EPS Beat by 1206 on Strong Operating Performance Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines